Antares Pharma (ATRS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 53,137 | 50,172 | 43,558 | 33,814 | 23,201 |
| Marketable Securities | N/A | 1,997 | 7,992 | 16,503 | 22,520 |
| Receivables | 42,221 | 42,507 | 34,293 | 31,412 | 35,074 |
| Inventories | 18,216 | 19,809 | 19,605 | 17,309 | 16,000 |
| Other current assets | 8,140 | 8,784 | 7,013 | 9,929 | 8,235 |
| TOTAL | $126,591 | $125,120 | $115,763 | $112,332 | $108,446 |
| Non-Current Assets | |||||
| PPE Net | 24,020 | 22,547 | 19,452 | 16,223 | 15,961 |
| Intangibles | 8,788 | 0 | 0 | 1,543 | 1,573 |
| Other Non-Current Assets | 53,132 | 7,907 | 7,909 | 6,706 | 6,771 |
| TOTAL | $85,940 | $30,454 | $27,361 | $24,472 | $24,305 |
| Total Assets | $212,531 | $155,574 | $143,124 | $136,804 | $132,751 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 16,230 | 6,415 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 16,194 | 18,016 | 18,071 | 18,184 | 12,905 |
| Accrued Expenses | 25,635 | 22,846 | 18,332 | 15,743 | 16,523 |
| TOTAL | $63,205 | $50,554 | $39,974 | $37,261 | $32,415 |
| Non-Current Liabilities | |||||
| Long Term Debt | 24,669 | 34,358 | 40,647 | 40,521 | 40,395 |
| Deferred Revenues | 3,943 | 3,277 | 2,341 | 2,048 | 1,738 |
| Other Non-Current Liabilities | 5,542 | 5,421 | 5,174 | 5,224 | 5,441 |
| TOTAL | $30,211 | $39,779 | $45,821 | $45,745 | $45,836 |
| Total Liabilities | $93,416 | $90,333 | $85,795 | $83,006 | $78,251 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 168,161 | 166,672 | 166,094 | 165,560 | 165,560 |
| Common Shares | 1,668 | 1,667 | 1,661 | 1,656 | 1,652 |
| Retained earnings | -222,626 | -274,012 | -279,008 | -281,183 | -278,827 |
| Other shareholders' equity | -683 | -691 | -696 | -700 | -702 |
| TOTAL | $119,115 | $65,241 | $57,329 | $53,798 | $54,500 |
| Total Liabilities And Equity | $212,531 | $155,574 | $143,124 | $136,804 | $132,751 |